LCTX · Lineage Cell Therapeutics, Inc.
$1.08
-0.02 (-1.82%)
At close · Sep 4
View the 10-K filed Mar 5, 2026
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$273.14M
Shares
252.91M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-12 | 205 | $1.12 | $230 |
| 2026-08-11 | 376 | $1.13 | $425 |
| 2026-08-10 | 284 | $1.10 | $312 |
| 2026-08-07 | 116 | $1.13 | $131 |
| 2026-08-04 | 43,612 | $1.11 | $48,409 |
| 2026-08-03 | 18 | $1.08 | $19 |
| 2026-07-31 | 68 | $1.11 | $75 |
| 2026-07-30 | 2,027 | $1.06 | $2,149 |
| 2026-07-29 | 666 | $1.07 | $713 |
| 2026-07-21 | 569 | $1.10 | $626 |
| 2026-07-17 | 7,768 | $1.17 | $9,089 |
| 2026-07-01 | 2,698 | $1.31 | $3,534 |
| 2026-06-30 | 14,119 | $1.35 | $19,061 |
| 2026-06-25 | 154 | $1.26 | $194 |
| 2026-06-24 | 1,818 | $1.25 | $2,273 |
| 2026-06-23 | 9 | $1.26 | $11 |
| 2026-06-22 | 9 | $1.21 | $11 |
| 2026-06-15 | 49 | $1.27 | $62 |
Showing 1–18 of 18 settlements
Key facts
CIK
876343
CUSIP
53566P109
13F (30d)
79 filings
79 filers
Visit website
Investor relations